Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Horvath

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Langenbeck'S Archives of Surgery|August 7, 2015
Overall morbidity but not mortality is increased in elderly patients following cytoreductive surgery and HIPECStefan Beckert, Florian Struller, Philipp Horvath, et al.
Annals of Transplantation|June 25, 2013
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in a liver graft recipient: a case reportPhilipp Horvath, Ingmar Königsrainer, Silvio Nadalin, et al.
Journal of Clinical Medicine|July 29, 2023
Possible Advantages of Minimal-Invasive Approaches in Rectal Cancer Surgery: A Nationwide AnalysisPhilipp Horvath, Christoph Steidle, Can Yurttas, et al.
Langenbeck'S Archives of Surgery|March 5, 2013
Risk factors for recurrence following complete cytoreductive surgery and HIPEC in colorectal cancer-derived peritoneal surface malignanciesIngmar Königsrainer, Philipp Horvath, Florian Struller, et al.
Annals of Surgical Oncology|November 9, 2020
In-Hospital Mortality and Complication Rates According to Health Insurance Data in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies in GermanyLisa Überrück, Giorgi Nadiradze, Can Yurttas, et al.
Pleura and Peritoneum|March 27, 2019
Morphology of the peritoneal cavity and pathophysiological consequencesWiebke Solass, Florian Struller, Philipp Horvath, et al.
Gastroenterology Research and Practice|November 27, 2018
Feasibility, Safety, and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastasis: A Registry StudyFlorian Kurtz, Florian Struller, Philipp Horvath, et al.
Langenbeck'S Archives of Surgery|May 13, 2014
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in recurrent epithelial ovarian cancer with peritoneal metastases: a single centre experienceIngmar Königsrainer, Philipp Horvath, Florian Struller, et al.
Cancers|December 28, 2019
Overcoming Drug Resistance by Taking Advantage of Physical Principles: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)Giorgi Nadiradze, Philipp Horvath, Yaroslav Sautkin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 4, 2021
Cost-effectiveness analysis of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with gastric cancer and peritoneal metastasisMehdi Javanbakht, Atefeh Mashayekhi, Michael Branagan-Harris, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Langenbeck'S Archives of Surgery|August 7, 2015
Overall morbidity but not mortality is increased in elderly patients following cytoreductive surgery and HIPECStefan Beckert, Florian Struller, Philipp Horvath, et al.
Annals of Transplantation|June 25, 2013
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in a liver graft recipient: a case reportPhilipp Horvath, Ingmar Königsrainer, Silvio Nadalin, et al.
Journal of Clinical Medicine|July 29, 2023
Possible Advantages of Minimal-Invasive Approaches in Rectal Cancer Surgery: A Nationwide AnalysisPhilipp Horvath, Christoph Steidle, Can Yurttas, et al.
Langenbeck'S Archives of Surgery|March 5, 2013
Risk factors for recurrence following complete cytoreductive surgery and HIPEC in colorectal cancer-derived peritoneal surface malignanciesIngmar Königsrainer, Philipp Horvath, Florian Struller, et al.
Annals of Surgical Oncology|November 9, 2020
In-Hospital Mortality and Complication Rates According to Health Insurance Data in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies in GermanyLisa Überrück, Giorgi Nadiradze, Can Yurttas, et al.
Pleura and Peritoneum|March 27, 2019
Morphology of the peritoneal cavity and pathophysiological consequencesWiebke Solass, Florian Struller, Philipp Horvath, et al.
Gastroenterology Research and Practice|November 27, 2018
Feasibility, Safety, and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastasis: A Registry StudyFlorian Kurtz, Florian Struller, Philipp Horvath, et al.
Langenbeck'S Archives of Surgery|May 13, 2014
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in recurrent epithelial ovarian cancer with peritoneal metastases: a single centre experienceIngmar Königsrainer, Philipp Horvath, Florian Struller, et al.
Cancers|December 28, 2019
Overcoming Drug Resistance by Taking Advantage of Physical Principles: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)Giorgi Nadiradze, Philipp Horvath, Yaroslav Sautkin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 4, 2021
Cost-effectiveness analysis of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with gastric cancer and peritoneal metastasisMehdi Javanbakht, Atefeh Mashayekhi, Michael Branagan-Harris, et al.
Pageof 4